

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.99034313 |
| 2 | transcytosis (GO:0045056) | 8.61862251 |
| 3 | cobalamin metabolic process (GO:0009235) | 8.06213332 |
| 4 | daunorubicin metabolic process (GO:0044597) | 7.49190881 |
| 5 | polyketide metabolic process (GO:0030638) | 7.49190881 |
| 6 | doxorubicin metabolic process (GO:0044598) | 7.49190881 |
| 7 | peptidyl-proline hydroxylation (GO:0019511) | 7.46011260 |
| 8 | cholesterol catabolic process (GO:0006707) | 7.41665590 |
| 9 | sterol catabolic process (GO:0016127) | 7.41665590 |
| 10 | regulation of phospholipase A2 activity (GO:0032429) | 7.11674683 |
| 11 | negative regulation of digestive system process (GO:0060457) | 6.91079893 |
| 12 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.74254921 |
| 13 | negative regulation of epidermis development (GO:0045683) | 6.40028275 |
| 14 | cysteine metabolic process (GO:0006534) | 6.16436360 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 5.79000021 |
| 16 | COPI coating of Golgi vesicle (GO:0048205) | 5.79000021 |
| 17 | protein hydroxylation (GO:0018126) | 5.75076944 |
| 18 | proline biosynthetic process (GO:0006561) | 5.59479036 |
| 19 | branched-chain amino acid catabolic process (GO:0009083) | 5.46040486 |
| 20 | ceramide catabolic process (GO:0046514) | 5.43394359 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 5.33934555 |
| 22 | valine metabolic process (GO:0006573) | 5.23112183 |
| 23 | tetrapyrrole metabolic process (GO:0033013) | 5.14723273 |
| 24 | intestinal epithelial cell development (GO:0060576) | 4.87324926 |
| 25 | regulation of keratinocyte differentiation (GO:0045616) | 4.86351585 |
| 26 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.83321703 |
| 27 | branched-chain amino acid metabolic process (GO:0009081) | 4.78250814 |
| 28 | cellular modified amino acid catabolic process (GO:0042219) | 4.74062851 |
| 29 | leukotriene biosynthetic process (GO:0019370) | 4.68759457 |
| 30 | zinc ion transport (GO:0006829) | 4.67333462 |
| 31 | glycoside metabolic process (GO:0016137) | 4.62024440 |
| 32 | positive regulation of nuclease activity (GO:0032075) | 4.61729406 |
| 33 | regulation of keratinocyte proliferation (GO:0010837) | 4.60587377 |
| 34 | protein maturation by protein folding (GO:0022417) | 4.51691205 |
| 35 | mitochondrial calcium ion transport (GO:0006851) | 4.51668396 |
| 36 | response to endoplasmic reticulum stress (GO:0034976) | 4.46132185 |
| 37 | angiotensin maturation (GO:0002003) | 4.45924305 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.37250334 |
| 39 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.34413378 |
| 40 | serine family amino acid biosynthetic process (GO:0009070) | 4.32875825 |
| 41 | antibacterial humoral response (GO:0019731) | 4.30721812 |
| 42 | cellular response to unfolded protein (GO:0034620) | 4.22416256 |
| 43 | regulation of nuclease activity (GO:0032069) | 4.20138243 |
| 44 | maintenance of protein localization in organelle (GO:0072595) | 4.19631437 |
| 45 | signal peptide processing (GO:0006465) | 4.15295417 |
| 46 | 4-hydroxyproline metabolic process (GO:0019471) | 4.09742715 |
| 47 | neutrophil mediated immunity (GO:0002446) | 4.09459726 |
| 48 | GDP-mannose metabolic process (GO:0019673) | 4.05076787 |
| 49 | regulation of guanylate cyclase activity (GO:0031282) | 4.04074621 |
| 50 | antimicrobial humoral response (GO:0019730) | 4.03441422 |
| 51 | primary alcohol catabolic process (GO:0034310) | 4.01683592 |
| 52 | cellular response to topologically incorrect protein (GO:0035967) | 4.01330382 |
| 53 | positive regulation of heat generation (GO:0031652) | 4.00612269 |
| 54 | ER-nucleus signaling pathway (GO:0006984) | 4.00327733 |
| 55 | aspartate family amino acid catabolic process (GO:0009068) | 3.94832442 |
| 56 | COPII vesicle coating (GO:0048208) | 3.94349622 |
| 57 | water-soluble vitamin metabolic process (GO:0006767) | 3.91727245 |
| 58 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.84062391 |
| 59 | glutamine metabolic process (GO:0006541) | 3.81838792 |
| 60 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80514774 |
| 61 | regulation of fever generation (GO:0031620) | 3.79561317 |
| 62 | steroid catabolic process (GO:0006706) | 3.76754544 |
| 63 | progesterone metabolic process (GO:0042448) | 3.74698914 |
| 64 | proline metabolic process (GO:0006560) | 3.73352648 |
| 65 | mucosal immune response (GO:0002385) | 3.72381691 |
| 66 | endocrine pancreas development (GO:0031018) | 3.71658149 |
| 67 | cellular glucuronidation (GO:0052695) | 3.70136098 |
| 68 | phosphatidylserine metabolic process (GO:0006658) | 3.66351764 |
| 69 | glucuronate metabolic process (GO:0019585) | 3.64520407 |
| 70 | uronic acid metabolic process (GO:0006063) | 3.64520407 |
| 71 | digestive system process (GO:0022600) | 3.63204110 |
| 72 | icosanoid secretion (GO:0032309) | 3.61096826 |
| 73 | arachidonic acid secretion (GO:0050482) | 3.61096826 |
| 74 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.60144227 |
| 75 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.59686378 |
| 76 | cellular protein catabolic process (GO:0044257) | 3.55901003 |
| 77 | sphingolipid catabolic process (GO:0030149) | 3.55276495 |
| 78 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.54362653 |
| 79 | creatine metabolic process (GO:0006600) | 3.54055014 |
| 80 | ER overload response (GO:0006983) | 3.53813080 |
| 81 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.51001359 |
| 82 | coenzyme catabolic process (GO:0009109) | 3.50529058 |
| 83 | regulation of cholesterol homeostasis (GO:2000188) | 3.49958831 |
| 84 | response to unfolded protein (GO:0006986) | 3.47894416 |
| 85 | cyclooxygenase pathway (GO:0019371) | 3.47521345 |
| 86 | retinoid metabolic process (GO:0001523) | 3.46144632 |
| 87 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.42257937 |
| 88 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.41381042 |
| 89 | L-serine metabolic process (GO:0006563) | 3.39385072 |
| 90 | phosphatidic acid metabolic process (GO:0046473) | 3.38549175 |
| 91 | phosphatidic acid biosynthetic process (GO:0006654) | 3.38549175 |
| 92 | organ or tissue specific immune response (GO:0002251) | 3.37922101 |
| 93 | sterol transport (GO:0015918) | 3.36494403 |
| 94 | cholesterol transport (GO:0030301) | 3.36494403 |
| 95 | * membrane lipid catabolic process (GO:0046466) | 3.35855365 |
| 96 | response to topologically incorrect protein (GO:0035966) | 3.34901583 |
| 97 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.34790911 |
| 98 | peptidyl-asparagine modification (GO:0018196) | 3.32660050 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 3.31371349 |
| 100 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.31368631 |
| 101 | vitamin metabolic process (GO:0006766) | 3.31323372 |
| 102 | diterpenoid metabolic process (GO:0016101) | 3.28075872 |
| 103 | alditol phosphate metabolic process (GO:0052646) | 3.23695311 |
| 104 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.22502257 |
| 105 | L-phenylalanine catabolic process (GO:0006559) | 3.22502257 |
| 106 | innate immune response in mucosa (GO:0002227) | 3.20804053 |
| 107 | macroautophagy (GO:0016236) | 3.18613225 |
| 108 | mitochondrion distribution (GO:0048311) | 3.17864904 |
| 109 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.17252672 |
| 110 | negative regulation of hormone metabolic process (GO:0032351) | 3.12123193 |
| 111 | cell redox homeostasis (GO:0045454) | 3.10277173 |
| 112 | myeloid leukocyte mediated immunity (GO:0002444) | 3.08409821 |
| 113 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.07646880 |
| 114 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.07565475 |
| 115 | L-phenylalanine metabolic process (GO:0006558) | 3.07565475 |
| 116 | regulation of digestive system process (GO:0044058) | 3.07016254 |
| 117 | regulation of vitamin metabolic process (GO:0030656) | 3.06828048 |
| 118 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 3.06439482 |
| 119 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.05648447 |
| 120 | acute-phase response (GO:0006953) | 3.05511979 |
| 121 | protein N-linked glycosylation (GO:0006487) | 3.05184402 |
| 122 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.05069850 |
| 123 | quinone metabolic process (GO:1901661) | 3.02736765 |
| 124 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.01506569 |
| 125 | regulation of epidermal cell differentiation (GO:0045604) | 3.00876362 |
| 126 | biotin metabolic process (GO:0006768) | 3.00828339 |
| 127 | sulfur amino acid biosynthetic process (GO:0000097) | 3.00739814 |
| 128 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.99185434 |
| 129 | regulation of heat generation (GO:0031650) | 2.98173477 |
| 130 | fatty acid derivative transport (GO:1901571) | 2.97045502 |
| 131 | icosanoid transport (GO:0071715) | 2.97045502 |
| 132 | peptide catabolic process (GO:0043171) | 2.96416948 |
| 133 | terpenoid metabolic process (GO:0006721) | 2.93443341 |
| 134 | multicellular organismal catabolic process (GO:0044243) | 2.93343161 |
| 135 | glycine transport (GO:0015816) | 2.92355967 |
| 136 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.90496727 |
| 137 | defense response to Gram-positive bacterium (GO:0050830) | 2.89126665 |
| 138 | leukotriene metabolic process (GO:0006691) | 2.87785589 |
| 139 | renal absorption (GO:0070293) | 2.87534291 |
| 140 | endothelial cell migration (GO:0043542) | 2.84130469 |
| 141 | regulation of oxidative stress-induced cell death (GO:1903201) | 2.83009318 |
| 142 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.81974876 |
| 143 | NADH metabolic process (GO:0006734) | 2.81947755 |
| 144 | multicellular organismal metabolic process (GO:0044236) | 2.81451013 |
| 145 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.79825660 |
| 146 | negative regulation of cell fate commitment (GO:0010454) | 2.78076117 |
| 147 | positive regulation of lipid catabolic process (GO:0050996) | 2.75103585 |
| 148 | phototransduction, visible light (GO:0007603) | 2.71411592 |
| 149 | epoxygenase P450 pathway (GO:0019373) | 2.70543830 |
| 150 | L-ascorbic acid metabolic process (GO:0019852) | 2.70163739 |
| 151 | negative regulation of epithelial cell differentiation (GO:0030857) | 2.67367342 |
| 152 | retinal metabolic process (GO:0042574) | 2.62862098 |
| 153 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.61720305 |
| 154 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.61720305 |
| 155 | endocrine process (GO:0050886) | 2.61720305 |
| 156 | phosphatidylglycerol metabolic process (GO:0046471) | 2.60505752 |
| 157 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.58999934 |
| 158 | intestinal cholesterol absorption (GO:0030299) | 18.9064831 |
| 159 | exocrine pancreas development (GO:0031017) | 15.7186113 |
| 160 | * digestion (GO:0007586) | 13.4351324 |
| 161 | protein retention in ER lumen (GO:0006621) | 12.3379279 |
| 162 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 11.5239104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.96455102 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.08073483 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.95810114 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.57765595 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.05480287 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.94787860 |
| 7 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.86736628 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.83288521 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.81043167 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75438304 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69271578 |
| 12 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.44966067 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.38000533 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36018033 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.25090425 |
| 16 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.24286918 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.20742305 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16421954 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15980475 |
| 20 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.12535273 |
| 21 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.12535273 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.12535273 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.00944620 |
| 24 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.85663452 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.82572934 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71273447 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.68662639 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67313409 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.64840850 |
| 30 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.64143080 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61279842 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60461569 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60296564 |
| 34 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.58071984 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55068297 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53989798 |
| 37 | NFYA_21822215_ChIP-Seq_K562_Human | 1.53094073 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52410201 |
| 39 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.50332255 |
| 40 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.49460865 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48954876 |
| 42 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.44731166 |
| 43 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.44728816 |
| 44 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44212277 |
| 45 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43907064 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43738065 |
| 47 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.42593704 |
| 48 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.42215928 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42209114 |
| 50 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.41914343 |
| 51 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.40069866 |
| 52 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39994133 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39303806 |
| 54 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.37411423 |
| 55 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.35711569 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34577359 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33147058 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30799270 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.29753675 |
| 60 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28145946 |
| 61 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.28127312 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26391638 |
| 63 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.25583128 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24354785 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22482105 |
| 66 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.21687035 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21467285 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20960879 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20468590 |
| 70 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.19072029 |
| 71 | NFYB_21822215_ChIP-Seq_K562_Human | 1.18235883 |
| 72 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15270723 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15095303 |
| 74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.14419678 |
| 75 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.14191058 |
| 76 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11802180 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11211036 |
| 78 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.10889491 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10822455 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09980693 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09757283 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.09291032 |
| 83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08222240 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08027450 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07441843 |
| 86 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.07386280 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07225712 |
| 88 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.07172647 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06593419 |
| 90 | ERA_21632823_ChIP-Seq_H3396_Human | 1.06584175 |
| 91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06296942 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06228178 |
| 93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05184023 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03962788 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02091322 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01974871 |
| 97 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01036520 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01017822 |
| 99 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.00887014 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00839484 |
| 101 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00465458 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99921455 |
| 103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98540268 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97467519 |
| 105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97220815 |
| 106 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.96932110 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94783891 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94252623 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94000049 |
| 110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.93498974 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93378235 |
| 112 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.93060658 |
| 113 | TBL1_22424771_ChIP-Seq_293T_Human | 0.92217042 |
| 114 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91819784 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90716321 |
| 116 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90511772 |
| 117 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.89067184 |
| 118 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88850417 |
| 119 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.88291526 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87628425 |
| 121 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87415812 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86000106 |
| 123 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85405930 |
| 124 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85297259 |
| 125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85165687 |
| 126 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.84679238 |
| 127 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84652330 |
| 128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83012131 |
| 129 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82993367 |
| 130 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.82893512 |
| 131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82101277 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82058763 |
| 133 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.81650079 |
| 134 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.81580668 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81415642 |
| 136 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.80774764 |
| 137 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.80713243 |
| 138 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80211355 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.79347797 |
| 140 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79232132 |
| 141 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79188960 |
| 142 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78675954 |
| 143 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78421994 |
| 144 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77847898 |
| 145 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77121931 |
| 146 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.77043447 |
| 147 | P300_27268052_Chip-Seq_Bcells_Human | 0.76805839 |
| 148 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.76662428 |
| 149 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.76451487 |
| 150 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.76199020 |
| 151 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.74700190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 9.32213740 |
| 2 | * MP0001666_abnormal_nutrient_absorption | 8.41194906 |
| 3 | MP0005365_abnormal_bile_salt | 6.62489344 |
| 4 | MP0005220_abnormal_exocrine_pancreas | 6.29415171 |
| 5 | MP0003868_abnormal_feces_composition | 5.07838354 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 5.03490021 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.65147262 |
| 8 | MP0001664_abnormal_digestion | 2.85978259 |
| 9 | MP0002693_abnormal_pancreas_physiology | 2.66246465 |
| 10 | MP0008004_abnormal_stomach_pH | 2.62236330 |
| 11 | MP0003959_abnormal_lean_body | 2.49992515 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.40790481 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.13217554 |
| 14 | MP0009840_abnormal_foam_cell | 2.08155874 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.06484443 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.03398553 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 1.97838864 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.94260376 |
| 19 | MP0001944_abnormal_pancreas_morphology | 1.79867279 |
| 20 | MP0005448_abnormal_energy_balance | 1.73249449 |
| 21 | MP0010386_abnormal_urinary_bladder | 1.66898146 |
| 22 | MP0003252_abnormal_bile_duct | 1.56162392 |
| 23 | MP0003638_abnormal_response/metabolism_ | 1.42947880 |
| 24 | MP0004233_abnormal_muscle_weight | 1.40481663 |
| 25 | MP0004147_increased_porphyrin_level | 1.33923778 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.33258192 |
| 27 | MP0000470_abnormal_stomach_morphology | 1.31880401 |
| 28 | MP0005165_increased_susceptibility_to | 1.29542729 |
| 29 | MP0005332_abnormal_amino_acid | 1.28177140 |
| 30 | MP0001873_stomach_inflammation | 1.23916003 |
| 31 | * MP0002118_abnormal_lipid_homeostasis | 1.23401544 |
| 32 | MP0005451_abnormal_body_composition | 1.16788310 |
| 33 | MP0005360_urolithiasis | 1.11799300 |
| 34 | MP0003866_abnormal_defecation | 1.11088639 |
| 35 | MP0002928_abnormal_bile_duct | 1.09461922 |
| 36 | MP0002078_abnormal_glucose_homeostasis | 1.02785832 |
| 37 | MP0000490_abnormal_crypts_of | 0.96759277 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 0.95199097 |
| 39 | MP0000538_abnormal_urinary_bladder | 0.93031426 |
| 40 | MP0005408_hypopigmentation | 0.90040984 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 0.89916549 |
| 42 | MP0009643_abnormal_urine_homeostasis | 0.89600846 |
| 43 | MP0003879_abnormal_hair_cell | 0.89312212 |
| 44 | MP0002132_abnormal_respiratory_system | 0.88312120 |
| 45 | MP0000003_abnormal_adipose_tissue | 0.87723046 |
| 46 | MP0001501_abnormal_sleep_pattern | 0.86487753 |
| 47 | MP0006054_spinal_hemorrhage | 0.84937891 |
| 48 | MP0003195_calcinosis | 0.84619801 |
| 49 | MP0001663_abnormal_digestive_system | 0.84110345 |
| 50 | MP0009384_cardiac_valve_regurgitation | 0.82863618 |
| 51 | MP0010329_abnormal_lipoprotein_level | 0.81728751 |
| 52 | MP0005166_decreased_susceptibility_to | 0.80808624 |
| 53 | MP0003953_abnormal_hormone_level | 0.79491385 |
| 54 | MP0005670_abnormal_white_adipose | 0.77961240 |
| 55 | MP0002163_abnormal_gland_morphology | 0.76762835 |
| 56 | MP0005535_abnormal_body_temperature | 0.76581967 |
| 57 | MP0009379_abnormal_foot_pigmentation | 0.74278635 |
| 58 | MP0008789_abnormal_olfactory_epithelium | 0.73264611 |
| 59 | MP0002822_catalepsy | 0.72010551 |
| 60 | MP0005381_digestive/alimentary_phenotyp | 0.71508045 |
| 61 | MP0000613_abnormal_salivary_gland | 0.68896742 |
| 62 | MP0008961_abnormal_basal_metabolism | 0.67812515 |
| 63 | MP0005058_abnormal_lysosome_morphology | 0.66570407 |
| 64 | MP0003045_fibrosis | 0.64983263 |
| 65 | MP0003300_gastrointestinal_ulcer | 0.64748215 |
| 66 | MP0002136_abnormal_kidney_physiology | 0.64607801 |
| 67 | MP0000477_abnormal_intestine_morphology | 0.63812143 |
| 68 | MP0005452_abnormal_adipose_tissue | 0.62338709 |
| 69 | MP0001764_abnormal_homeostasis | 0.61212412 |
| 70 | MP0000598_abnormal_liver_morphology | 0.60075254 |
| 71 | MP0003183_abnormal_peptide_metabolism | 0.56630747 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.55659179 |
| 73 | MP0000609_abnormal_liver_physiology | 0.55419963 |
| 74 | MP0002909_abnormal_adrenal_gland | 0.55346386 |
| 75 | MP0002796_impaired_skin_barrier | 0.55181546 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 0.55118002 |
| 77 | MP0003283_abnormal_digestive_organ | 0.55081529 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.54655389 |
| 79 | MP0003186_abnormal_redox_activity | 0.54569178 |
| 80 | MP0005499_abnormal_olfactory_system | 0.53532423 |
| 81 | MP0005394_taste/olfaction_phenotype | 0.53532423 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.53165285 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 0.52328371 |
| 84 | MP0005409_darkened_coat_color | 0.51739642 |
| 85 | MP0008260_abnormal_autophagy | 0.51008241 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.50937728 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.50022535 |
| 88 | MP0008469_abnormal_protein_level | 0.48207627 |
| 89 | MP0002970_abnormal_white_adipose | 0.47528373 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.47004677 |
| 91 | MP0002060_abnormal_skin_morphology | 0.44178890 |
| 92 | MP0001845_abnormal_inflammatory_respons | 0.43259083 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.42593278 |
| 94 | MP0009764_decreased_sensitivity_to | 0.42014602 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.40825582 |
| 96 | MP0004043_abnormal_pH_regulation | 0.40553611 |
| 97 | MP0005334_abnormal_fat_pad | 0.38634523 |
| 98 | MP0000377_abnormal_hair_follicle | 0.38579217 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.38216629 |
| 100 | MP0010678_abnormal_skin_adnexa | 0.37325667 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.36160127 |
| 102 | MP0000750_abnormal_muscle_regeneration | 0.35931080 |
| 103 | MP0000367_abnormal_coat/_hair | 0.35616616 |
| 104 | MP0001502_abnormal_circadian_rhythm | 0.34557197 |
| 105 | MP0003795_abnormal_bone_structure | 0.34552318 |
| 106 | MP0003011_delayed_dark_adaptation | 0.34385158 |
| 107 | MP0000462_abnormal_digestive_system | 0.34335301 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.34253078 |
| 109 | MP0004858_abnormal_nervous_system | 0.33810680 |
| 110 | MP0003718_maternal_effect | 0.33593043 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 0.33489612 |
| 112 | * MP0001731_abnormal_postnatal_growth | 0.33409439 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.32849156 |
| 114 | MP0005187_abnormal_penis_morphology | 0.32737899 |
| 115 | MP0000371_diluted_coat_color | 0.32199953 |
| 116 | MP0003436_decreased_susceptibility_to | 0.31816511 |
| 117 | MP0003329_amyloid_beta_deposits | 0.31674494 |
| 118 | MP0000537_abnormal_urethra_morphology | 0.31526710 |
| 119 | MP0005501_abnormal_skin_physiology | 0.31026231 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30220441 |
| 121 | MP0000858_altered_metastatic_potential | 0.29738389 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.29182347 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.29166671 |
| 124 | MP0008872_abnormal_physiological_respon | 0.28823930 |
| 125 | MP0004484_altered_response_of | 0.28365333 |
| 126 | MP0000647_abnormal_sebaceous_gland | 0.27701946 |
| 127 | MP0005636_abnormal_mineral_homeostasis | 0.25523686 |
| 128 | MP0001756_abnormal_urination | 0.24992733 |
| 129 | MP0000566_synostosis | 0.24980160 |
| 130 | MP0001849_ear_inflammation | 0.24751607 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.23752598 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.23120160 |
| 133 | MP0010155_abnormal_intestine_physiology | 0.22761584 |
| 134 | MP0000579_abnormal_nail_morphology | 0.22564289 |
| 135 | MP0008875_abnormal_xenobiotic_pharmacok | 0.22179463 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.21890732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 8.43674076 |
| 2 | Fat malabsorption (HP:0002630) | 7.32474911 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.06535470 |
| 4 | Gout (HP:0001997) | 6.80014489 |
| 5 | Hydroxyprolinuria (HP:0003080) | 6.38845491 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 6.38845491 |
| 7 | Short chin (HP:0000331) | 5.49591232 |
| 8 | Decreased subcutaneous fat (HP:0001002) | 5.32632191 |
| 9 | Exocrine pancreatic insufficiency (HP:0001738) | 5.19333124 |
| 10 | Abnormality of subcutaneous fat tissue (HP:0001001) | 4.86424646 |
| 11 | Type I diabetes mellitus (HP:0100651) | 4.77166435 |
| 12 | Abnormal pancreas size (HP:0012094) | 4.69282228 |
| 13 | Tetraparesis (HP:0002273) | 4.60235562 |
| 14 | Ileus (HP:0002595) | 4.59734214 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 4.39753264 |
| 16 | Malnutrition (HP:0004395) | 4.35394830 |
| 17 | Hypoplasia of the pons (HP:0012110) | 4.18209400 |
| 18 | Maternal diabetes (HP:0009800) | 4.13699451 |
| 19 | Abnormality of the pons (HP:0007361) | 3.90856743 |
| 20 | Pancreatitis (HP:0001733) | 3.82428499 |
| 21 | Premature skin wrinkling (HP:0100678) | 3.65434055 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.58138919 |
| 23 | Ketosis (HP:0001946) | 3.57686209 |
| 24 | Ketoacidosis (HP:0001993) | 3.53700935 |
| 25 | Tubulointerstitial fibrosis (HP:0005576) | 3.49319584 |
| 26 | Tubulointerstitial nephritis (HP:0001970) | 3.44606816 |
| 27 | Cortical dysplasia (HP:0002539) | 3.41652896 |
| 28 | Carpal bone hypoplasia (HP:0001498) | 3.38961716 |
| 29 | Joint stiffness (HP:0001387) | 3.28752224 |
| 30 | Hypoproteinemia (HP:0003075) | 3.28320661 |
| 31 | Increased purine levels (HP:0004368) | 3.22058577 |
| 32 | Hyperuricemia (HP:0002149) | 3.22058577 |
| 33 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.14646908 |
| 34 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.14646908 |
| 35 | Hyperglycinemia (HP:0002154) | 3.08152056 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.02048127 |
| 37 | Abnormality of the pleura (HP:0002103) | 3.00289495 |
| 38 | Hyperglycinuria (HP:0003108) | 2.98068255 |
| 39 | Ventricular fibrillation (HP:0001663) | 2.97546876 |
| 40 | Long foot (HP:0001833) | 2.94458952 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.90036260 |
| 42 | Abnormal tarsal ossification (HP:0008369) | 2.82412196 |
| 43 | Abnormality of vitamin B metabolism (HP:0004340) | 2.78810588 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.76468469 |
| 45 | Vascular calcification (HP:0004934) | 2.74819335 |
| 46 | Hypobetalipoproteinemia (HP:0003563) | 2.72063913 |
| 47 | Late onset (HP:0003584) | 2.71259231 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 2.71051036 |
| 49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71051036 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70647879 |
| 51 | Hypoglycemic seizures (HP:0002173) | 2.60670969 |
| 52 | Villous atrophy (HP:0011473) | 2.59807245 |
| 53 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.59807245 |
| 54 | Abnormal protein glycosylation (HP:0012346) | 2.56215590 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.56215590 |
| 56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.56215590 |
| 57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.56215590 |
| 58 | Abnormality of urine glucose concentration (HP:0011016) | 2.53363678 |
| 59 | Glycosuria (HP:0003076) | 2.53363678 |
| 60 | Rectal prolapse (HP:0002035) | 2.50185185 |
| 61 | Abnormality of vitamin metabolism (HP:0100508) | 2.48111056 |
| 62 | Fatigue (HP:0012378) | 2.47624214 |
| 63 | Abnormal biliary tract morphology (HP:0012440) | 2.47458130 |
| 64 | Progressive muscle weakness (HP:0003323) | 2.45394870 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.42352699 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.37725473 |
| 67 | Prenatal maternal abnormality (HP:0002686) | 2.35936123 |
| 68 | Paraparesis (HP:0002385) | 2.34050021 |
| 69 | Hypoplasia of the uterus (HP:0000013) | 2.33369817 |
| 70 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32103786 |
| 71 | Optic nerve hypoplasia (HP:0000609) | 2.31811278 |
| 72 | Megaloblastic anemia (HP:0001889) | 2.31324607 |
| 73 | Small epiphyses (HP:0010585) | 2.29820426 |
| 74 | Esophageal varix (HP:0002040) | 2.29467171 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.25470990 |
| 76 | Acute hepatic failure (HP:0006554) | 2.25196449 |
| 77 | Proximal tubulopathy (HP:0000114) | 2.24788775 |
| 78 | Hypoplasia of the odontoid process (HP:0003311) | 2.20352497 |
| 79 | Vacuolated lymphocytes (HP:0001922) | 2.19465728 |
| 80 | Pectus carinatum (HP:0000768) | 2.19129243 |
| 81 | Male infertility (HP:0003251) | 2.18717057 |
| 82 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.17306646 |
| 83 | Chronic diarrhea (HP:0002028) | 2.17000781 |
| 84 | Abnormal number of erythroid precursors (HP:0012131) | 2.16232711 |
| 85 | Congenital glaucoma (HP:0001087) | 2.15792529 |
| 86 | Congenital malformation of the right heart (HP:0011723) | 2.15565982 |
| 87 | Double outlet right ventricle (HP:0001719) | 2.15565982 |
| 88 | Widely patent fontanelles and sutures (HP:0004492) | 2.12980020 |
| 89 | Abnormality of the renal cortex (HP:0011035) | 2.12964763 |
| 90 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.12043968 |
| 91 | Xanthomatosis (HP:0000991) | 2.11099411 |
| 92 | Hyperglycemia (HP:0003074) | 2.10190894 |
| 93 | Hyperphosphatemia (HP:0002905) | 2.09756355 |
| 94 | Barrel-shaped chest (HP:0001552) | 2.08886782 |
| 95 | Prolonged QT interval (HP:0001657) | 2.08617795 |
| 96 | Sex reversal (HP:0012245) | 2.07115856 |
| 97 | Abnormal sex determination (HP:0012244) | 2.07115856 |
| 98 | Abnormal foot bone ossification (HP:0010675) | 2.06524902 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 2.06253262 |
| 100 | Ankyloglossia (HP:0010296) | 2.04400714 |
| 101 | Dysostosis multiplex (HP:0000943) | 2.04253636 |
| 102 | Tubular atrophy (HP:0000092) | 2.02695419 |
| 103 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.02179195 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.01107843 |
| 105 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.00917507 |
| 106 | Pigmentary retinal degeneration (HP:0001146) | 2.00162850 |
| 107 | Myocardial infarction (HP:0001658) | 2.00086558 |
| 108 | Congenital sensorineural hearing impairment (HP:0008527) | 1.99847628 |
| 109 | Methylmalonic aciduria (HP:0012120) | 1.98031550 |
| 110 | Type I transferrin isoform profile (HP:0003642) | 1.95760855 |
| 111 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.95117748 |
| 112 | Abnormality of methionine metabolism (HP:0010901) | 1.94653304 |
| 113 | Anal atresia (HP:0002023) | 1.93831917 |
| 114 | Tubulointerstitial abnormality (HP:0001969) | 1.93516471 |
| 115 | Cortical visual impairment (HP:0100704) | 1.92628446 |
| 116 | Flat acetabular roof (HP:0003180) | 1.89139978 |
| 117 | Homocystinuria (HP:0002156) | 1.89064127 |
| 118 | Abnormality of homocysteine metabolism (HP:0010919) | 1.89064127 |
| 119 | Severe short stature (HP:0003510) | 1.86142580 |
| 120 | Vertebral compression fractures (HP:0002953) | 1.85577776 |
| 121 | Popliteal pterygium (HP:0009756) | 1.83437431 |
| 122 | Syncope (HP:0001279) | 1.83275861 |
| 123 | Lower limb hyperreflexia (HP:0002395) | 1.82937307 |
| 124 | Flattened epiphyses (HP:0003071) | 1.82842785 |
| 125 | Symptomatic seizures (HP:0011145) | 1.82453007 |
| 126 | Intrahepatic cholestasis (HP:0001406) | 1.81781695 |
| 127 | Renal salt wasting (HP:0000127) | 1.81702460 |
| 128 | Opisthotonus (HP:0002179) | 1.81071382 |
| 129 | Type II lissencephaly (HP:0007260) | 1.80241703 |
| 130 | Abdominal distention (HP:0003270) | 1.80087798 |
| 131 | Potter facies (HP:0002009) | 1.79448304 |
| 132 | Facial shape deformation (HP:0011334) | 1.79448304 |
| 133 | Acanthocytosis (HP:0001927) | 1.78402738 |
| 134 | Nausea (HP:0002018) | 1.77951893 |
| 135 | Progressive sensorineural hearing impairment (HP:0000408) | 1.77824757 |
| 136 | Limb hypertonia (HP:0002509) | 1.77583821 |
| 137 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77352818 |
| 138 | Hyperammonemia (HP:0001987) | 1.76547343 |
| 139 | Glomerulosclerosis (HP:0000096) | 1.76494857 |
| 140 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.76403743 |
| 141 | Atrophic scars (HP:0001075) | 1.75824357 |
| 142 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73586971 |
| 143 | Dehydration (HP:0001944) | 1.69868166 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68893114 |
| 145 | Nephrolithiasis (HP:0000787) | 1.68349205 |
| 146 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.66653577 |
| 147 | Confusion (HP:0001289) | 1.66177027 |
| 148 | Wide cranial sutures (HP:0010537) | 1.63963040 |
| 149 | Large for gestational age (HP:0001520) | 1.63088954 |
| 150 | Subcapsular cataract (HP:0000523) | 1.62339763 |
| 151 | Metabolic acidosis (HP:0001942) | 1.62274751 |
| 152 | Abdominal pain (HP:0002027) | 1.62065757 |
| 153 | Renal tubular acidosis (HP:0001947) | 1.61751738 |
| 154 | Glomerulonephritis (HP:0000099) | 1.57953525 |
| 155 | Gastrointestinal dysmotility (HP:0002579) | 1.57720432 |
| 156 | Decreased circulating renin level (HP:0003351) | 1.57382784 |
| 157 | Increased CSF protein (HP:0002922) | 1.56858774 |
| 158 | Elevated alkaline phosphatase (HP:0003155) | 1.56447896 |
| 159 | Hypercalciuria (HP:0002150) | 1.51439464 |
| 160 | Hypophosphatemia (HP:0002148) | 1.47108339 |
| 161 | Abnormality of chloride homeostasis (HP:0011422) | 1.46690127 |
| 162 | Hypolipoproteinemia (HP:0010981) | 1.46096257 |
| 163 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.45859099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 9.40604721 |
| 2 | ERN1 | 5.23489687 |
| 3 | EIF2AK3 | 4.63139473 |
| 4 | MAP2K2 | 4.29313630 |
| 5 | ACVR1B | 3.39959942 |
| 6 | TRIB3 | 3.17142157 |
| 7 | FRK | 2.99830029 |
| 8 | PKN2 | 2.80327371 |
| 9 | PRKG2 | 2.67530672 |
| 10 | INSRR | 2.64326268 |
| 11 | MAP3K12 | 2.15196202 |
| 12 | MAPKAPK3 | 2.01968325 |
| 13 | TAOK3 | 1.92490996 |
| 14 | IRAK3 | 1.90293675 |
| 15 | ZAP70 | 1.88108503 |
| 16 | NME1 | 1.82872825 |
| 17 | MAPK15 | 1.76502963 |
| 18 | MAP2K1 | 1.73787251 |
| 19 | GRK1 | 1.67900101 |
| 20 | EIF2AK1 | 1.63379806 |
| 21 | PAK2 | 1.53828042 |
| 22 | SCYL2 | 1.51412707 |
| 23 | WNK4 | 1.35537810 |
| 24 | NME2 | 1.34450858 |
| 25 | PTK6 | 1.29391378 |
| 26 | CDK19 | 1.24911501 |
| 27 | RPS6KB2 | 1.22936117 |
| 28 | DYRK1A | 1.15606000 |
| 29 | MAP3K2 | 1.13181036 |
| 30 | NLK | 1.11590522 |
| 31 | PDGFRB | 1.10251439 |
| 32 | EEF2K | 1.05466660 |
| 33 | TESK1 | 1.05188274 |
| 34 | PIK3CG | 1.03054939 |
| 35 | PIK3CA | 1.02619551 |
| 36 | ERBB4 | 0.98744938 |
| 37 | LATS1 | 0.97186275 |
| 38 | PDK2 | 0.94570501 |
| 39 | FLT3 | 0.94311862 |
| 40 | MST1R | 0.93764996 |
| 41 | OXSR1 | 0.93336820 |
| 42 | EPHA2 | 0.91147674 |
| 43 | NTRK3 | 0.83857457 |
| 44 | CAMKK1 | 0.81522118 |
| 45 | MAP2K6 | 0.81012413 |
| 46 | PRKCI | 0.78466969 |
| 47 | SIK1 | 0.77400155 |
| 48 | MYLK | 0.76756596 |
| 49 | TAOK1 | 0.72322513 |
| 50 | BMPR1B | 0.69068030 |
| 51 | DYRK1B | 0.67685303 |
| 52 | MTOR | 0.67625029 |
| 53 | STK39 | 0.64587931 |
| 54 | IRAK2 | 0.64236843 |
| 55 | RIPK1 | 0.63861023 |
| 56 | STK24 | 0.60000112 |
| 57 | CAMKK2 | 0.59316150 |
| 58 | LMTK2 | 0.58510734 |
| 59 | STK16 | 0.58246909 |
| 60 | FER | 0.57446011 |
| 61 | FGFR3 | 0.57308768 |
| 62 | LRRK2 | 0.57079824 |
| 63 | DAPK2 | 0.57071860 |
| 64 | PDPK1 | 0.54460567 |
| 65 | TAOK2 | 0.53815999 |
| 66 | RET | 0.52885246 |
| 67 | MET | 0.51589375 |
| 68 | MAP3K5 | 0.51051400 |
| 69 | KSR2 | 0.49439899 |
| 70 | MAP3K11 | 0.49138202 |
| 71 | PRKCZ | 0.46934679 |
| 72 | EPHB1 | 0.46215528 |
| 73 | MAP3K10 | 0.45786869 |
| 74 | MAP3K1 | 0.45452718 |
| 75 | RPS6KB1 | 0.45338675 |
| 76 | TSSK6 | 0.43041599 |
| 77 | MAP3K9 | 0.42766932 |
| 78 | JAK1 | 0.41585403 |
| 79 | PINK1 | 0.41377684 |
| 80 | DAPK1 | 0.40742948 |
| 81 | IRAK4 | 0.40638752 |
| 82 | PRKCE | 0.40367446 |
| 83 | PTK2 | 0.39642101 |
| 84 | TRPM7 | 0.39346540 |
| 85 | PDK1 | 0.39127723 |
| 86 | PDK3 | 0.39100259 |
| 87 | PDK4 | 0.39100259 |
| 88 | BCR | 0.35255221 |
| 89 | FGFR4 | 0.35250272 |
| 90 | MAP3K3 | 0.34235506 |
| 91 | PRKCA | 0.33974935 |
| 92 | PRKCH | 0.33035534 |
| 93 | ERBB3 | 0.32778276 |
| 94 | PRKACG | 0.32537061 |
| 95 | NTRK1 | 0.31873274 |
| 96 | MAP3K7 | 0.31136137 |
| 97 | MAPK12 | 0.30691015 |
| 98 | MAP3K14 | 0.30085440 |
| 99 | ROCK1 | 0.29305872 |
| 100 | MAPK3 | 0.28947239 |
| 101 | PRKACB | 0.28166086 |
| 102 | NEK6 | 0.27975323 |
| 103 | IRAK1 | 0.27889048 |
| 104 | RPS6KA1 | 0.27051101 |
| 105 | DDR2 | 0.26973263 |
| 106 | MAPK7 | 0.26643527 |
| 107 | PRKD3 | 0.26393475 |
| 108 | MAP3K8 | 0.25159935 |
| 109 | EPHA3 | 0.24959882 |
| 110 | PDGFRA | 0.24875042 |
| 111 | NUAK1 | 0.24819820 |
| 112 | JAK2 | 0.24409830 |
| 113 | PRKAA2 | 0.24245507 |
| 114 | MELK | 0.22235394 |
| 115 | TIE1 | 0.21937361 |
| 116 | GRK6 | 0.21489988 |
| 117 | ABL1 | 0.20905279 |
| 118 | TBK1 | 0.20893066 |
| 119 | NEK1 | 0.20516626 |
| 120 | PRKD1 | 0.20338415 |
| 121 | BMPR2 | 0.20058947 |
| 122 | YES1 | 0.18138704 |
| 123 | ILK | 0.16996089 |
| 124 | PIM1 | 0.16094201 |
| 125 | STK38 | 0.15782528 |
| 126 | CAMK4 | 0.14583394 |
| 127 | CSNK1E | 0.14464040 |
| 128 | IGF1R | 0.13983693 |
| 129 | DAPK3 | 0.13913916 |
| 130 | MAPK1 | 0.13905504 |
| 131 | IKBKE | 0.13528038 |
| 132 | TYK2 | 0.13347088 |
| 133 | CSNK1A1 | 0.13308524 |
| 134 | PRKACA | 0.13220839 |
| 135 | CAMK2G | 0.13053528 |
| 136 | GSK3A | 0.12441271 |
| 137 | AKT3 | 0.12364161 |
| 138 | PIM2 | 0.12025566 |
| 139 | MAPK11 | 0.11684617 |
| 140 | SRC | 0.11244029 |
| 141 | MATK | 0.11206656 |
| 142 | PRKAA1 | 0.11047907 |
| 143 | PAK4 | 0.10836779 |
| 144 | ERBB2 | 0.10691624 |
| 145 | PRKCD | 0.10287988 |
| 146 | DYRK2 | 0.09467545 |
| 147 | HIPK2 | 0.09020798 |
| 148 | MST4 | 0.08147165 |
| 149 | PASK | 0.07668186 |
| 150 | EGFR | 0.07419402 |
| 151 | CAMK1D | 0.07188254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Pancreatic secretion_Homo sapiens_hsa04972 | 8.04891133 |
| 2 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.75351229 |
| 3 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 5.48583959 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.50080225 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.28618520 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.09762804 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.64727614 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.61352230 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36620520 |
| 10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.27803411 |
| 11 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.13490057 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12486506 |
| 13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.94502200 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.88803349 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72151192 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50003833 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44425043 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43716356 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.18768273 |
| 20 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16200540 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14868888 |
| 22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.10117450 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10101390 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00879817 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96341417 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95629627 |
| 27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94273316 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89511483 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86432561 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84217705 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82875169 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78374063 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78155084 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75342797 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 0.73260202 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73220027 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 0.71407583 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69922766 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69536582 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69277809 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68142104 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63262103 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63156977 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62356664 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61339601 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59766909 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59542963 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57924359 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57848284 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57792947 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57688002 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56562025 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55212421 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55194766 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52367983 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51279572 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51115133 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49337104 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46296730 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45913396 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43269133 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40719516 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39612950 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.38511518 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38475800 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36078811 |
| 67 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35073518 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34088103 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33408350 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33056984 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32733329 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30595969 |
| 73 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.29172672 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28882508 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27441683 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26202393 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.26136779 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26131390 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.25204235 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.24252951 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.23435806 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21608438 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20025502 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19485412 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19141942 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18420920 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.17773415 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17562137 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.17438866 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17165929 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16832894 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16500226 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16387453 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.15111412 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.14993064 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14931961 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.13947569 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.13002394 |
| 99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.10846722 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.10470540 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.08495410 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.08258770 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.06594357 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.06216017 |
| 105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.06019895 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.06017887 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05859006 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.05429555 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.05210507 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04001114 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.03875920 |
| 112 | Peroxisome_Homo sapiens_hsa04146 | 0.03267603 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03261285 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.03007791 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.01889021 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.01667055 |
| 117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.00893727 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.1114321 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1089181 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0917275 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0773354 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0703555 |
| 123 | Asthma_Homo sapiens_hsa05310 | -0.0598595 |
| 124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0532934 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0372040 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0349706 |
| 127 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0145558 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | -0.0051985 |
| 129 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0030292 |

